160 related articles for article (PubMed ID: 15081947)
1. Overview: from the horse experimentation by Prof. Akira Fujinami to paramyosin.
Kojima S
Parasitol Int; 2004 Jun; 53(2):151-62. PubMed ID: 15081947
[TBL] [Abstract][Full Text] [Related]
2. Cross-species prophylactic efficacy of Sm-p80-based vaccine and intracellular localization of Sm-p80/Sm-p80 ortholog proteins during development in Schistosoma mansoni, Schistosoma japonicum, and Schistosoma haematobium.
Molehin AJ; Sennoune SR; Zhang W; Rojo JU; Siddiqui AJ; Herrera KA; Johnson L; Sudduth J; May J; Siddiqui AA
Parasitol Res; 2017 Nov; 116(11):3175-3188. PubMed ID: 29026995
[TBL] [Abstract][Full Text] [Related]
3. Paramyosin: a candidate vaccine antigen against Schistosoma japonicum.
Ramirez BL; Kurtis JD; Wiest PM; Arias P; Aligui F; Acosta L; Peters P; Olds GR
Parasite Immunol; 1996 Jan; 18(1):49-52. PubMed ID: 9223156
[TBL] [Abstract][Full Text] [Related]
4. Intranasal administration of Schistosoma japonicum paramyosin induced robust long-lasting systemic and local antibody as well as delayed-type hypersensitivity responses, but failed to confer protection in a mouse infection model.
Kohama H; Harakuni T; Kikuchi M; Nara T; Takemura Y; Miyata T; Sato Y; Hirayama K; Arakawa T
Jpn J Infect Dis; 2010 May; 63(3):166-72. PubMed ID: 20495267
[TBL] [Abstract][Full Text] [Related]
5. Research on calpain of Schistosoma japonicum as a vaccine candidate.
Ohta N; Kumagai T; Maruyama H; Yoshida A; He Y; Zhang R
Parasitol Int; 2004 Jun; 53(2):175-81. PubMed ID: 15081949
[TBL] [Abstract][Full Text] [Related]
6. [Current status and prospects on candidate vaccines against Schistosoma japonicum].
Wen LY; Wu GL
Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi; 2007 Oct; 25(5):422-5, 429. PubMed ID: 18442002
[TBL] [Abstract][Full Text] [Related]
7. Schistosoma mansoni and S. japonicum worm numbers in 129/J mice of two types and dominance of susceptibility in F1 hybrids.
Wright MD; Tiu WU; Wood SM; Walker JC; Garcia EG; Mitchell GF
J Parasitol; 1988 Aug; 74(4):618-22. PubMed ID: 2969409
[TBL] [Abstract][Full Text] [Related]
8. Update on paramyosin in parasitic worms.
Gobert GN; McManus DP
Parasitol Int; 2005 Jun; 54(2):101-7. PubMed ID: 15866471
[TBL] [Abstract][Full Text] [Related]
9. [Studies on the mechanism of the protective immunity against Schistosoma japonicum--cellular immune responses].
Wu H; Xu ST
Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi; 1993; 11(1):41-4. PubMed ID: 8403276
[TBL] [Abstract][Full Text] [Related]
10. Peptides containing T cell epitopes, derived from Sm14, but not from paramyosin, induce a Th1 type of immune response, reduction in liver pathology and partial protection against Schistosoma mansoni infection in mice.
Garcia TC; Fonseca CT; Pacifico LG; Durães Fdo V; Marinho FA; Penido ML; Caliari MV; de Melo AL; Pinto HA; Barsante MM; Cunha-Neto E; Oliveira SC
Acta Trop; 2008 Jun; 106(3):162-7. PubMed ID: 18423420
[TBL] [Abstract][Full Text] [Related]
11. Current status and future prospects for a vaccine against schistosomiasis.
Lebens M; Sun JB; Czerkinsky C; Holmgren J
Expert Rev Vaccines; 2004 Jun; 3(3):315-28. PubMed ID: 15176948
[TBL] [Abstract][Full Text] [Related]
12. [Preliminary study on the immune response in C57BL/6 mice vaccinated by nucleic acid encoding paramyosin of Chinese S. japonicum].
Zhou S; Liu S; Song G
Zhonghua Yi Xue Za Zhi; 1999 Nov; 79(11):848-51. PubMed ID: 11715491
[TBL] [Abstract][Full Text] [Related]
13. The vaccine efficacy of native paramyosin (Sj-97) against Chinese Schistosoma japonicum.
McManus DP; Liu S; Song G; Xu Y; Wong JM
Int J Parasitol; 1998 Nov; 28(11):1739-42. PubMed ID: 9846611
[TBL] [Abstract][Full Text] [Related]
14. Prospects of vaccination against schistosomiasis.
Bergquist R
Scand J Infect Dis Suppl; 1990; 76():60-71. PubMed ID: 2102021
[TBL] [Abstract][Full Text] [Related]
15. [Anti-schistosomiasis effect induced by full length DNA vaccine coding paramyosin of Schistosoma japonicum in C57BL/6 mice].
Chen JX; Liu SX; Cao JP; Song GC; Xu YX
Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi; 2006 Apr; 24(2):81-5. PubMed ID: 16862901
[TBL] [Abstract][Full Text] [Related]
16. Development of a vaccine against Schistosoma japonicum in China: a review.
Wu ZD; Lü ZY; Yu XB
Acta Trop; 2005; 96(2-3):106-16. PubMed ID: 16168945
[TBL] [Abstract][Full Text] [Related]
17. Schistosoma mansoni and S. japonicum: comparison of levels of ultraviolet irradiation for vaccination of mice with cercariae.
Ruppel A; Shi YE; Moloney NA
Parasitology; 1990 Aug; 101 Pt 1():23-6. PubMed ID: 2122396
[TBL] [Abstract][Full Text] [Related]
18. IL-18 enhances protective effect in mice immunized with a Schistosoma japonicum FABP DNA vaccine.
Wei F; Liu Q; Zhai Y; Fu Z; Liu W; Shang L; Men J; Gao S; Lian H; Jin H; Chen C; Lin J; Shi Y; Xia Z; Zhu XQ
Acta Trop; 2009 Sep; 111(3):284-8. PubMed ID: 19467215
[TBL] [Abstract][Full Text] [Related]
19. Prospects for development of a transmission blocking vaccine against Schistosoma japonicum.
McManus DP
Parasite Immunol; 2005; 27(7-8):297-308. PubMed ID: 16138851
[TBL] [Abstract][Full Text] [Related]
20. Cloning and partial nucleotide sequence of Schistosoma japonicum paramyosin: a potential vaccine candidate against schistosomiasis.
Yang W; Waine GJ; Sculley DG; Liu X; McManus DP
Int J Parasitol; 1992 Dec; 22(8):1187-91. PubMed ID: 1487380
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
